Aging and cardiac implantable electronic device complications: is the procedure safe in older patients?

Basit Öğe Kaydı
dc.authoridGüzel, Tuncay/0000-0001-8470-1928
dc.authoridAYDIN, SAADET/0000-0003-0817-1026
dc.authoridTatli, Ismail/0000-0002-9800-2105
dc.authoridARPA, ABDULKADIR/0000-0002-6077-0416
dc.authoridKILIC, RAIF/0000-0002-8338-4948
dc.authoridArslan, Bayram/0000-0003-2984-9094
dc.authoridGunlu, Serhat/0000-0001-6985-6112
dc.authorwosidGüzel, Tuncay/AAC-9120-2022
dc.authorwosidAktan, Adem/GMX-2603-2022
dc.contributor.authorGuzel, Tuncay
dc.contributor.authorAktan, Adem
dc.contributor.authorKilic, Raif
dc.contributor.authorGunlu, Serhat
dc.contributor.authorArslan, Bayram
dc.contributor.authorArpa, Abdulkadir
dc.contributor.authorGuzel, Hamdullah
dc.date.accessioned2024-03-09T18:48:17Z
dc.date.available2024-03-09T18:48:17Z
dc.date.issued2023
dc.departmentİzmir Bakırçay Üniversitesien_US
dc.description.abstractBackgroundIn this study, we investigated whether there is a higher incidence of cardiac implantable electronic devices (CIED) procedures related complications in older (& GE; 75 years) than in younger (< 75 years) patients.MethodsThis retrospective cohort study enrolled patients who had undergone CIED procedures (de novo implantation, system upgrade, generator substitution, pocket revision or lead replacement) at two heart centers in Turkey between January 2011 and May 2023. The primary composite endpoint included clinically significant hematoma (CSH), pericardial effusion or tamponade, pneumothorax, and infection related to the device system. Secondary outcomes included each component of the composite end point.ResultsThe overall sample included 1923 patients (1419 < 75 years and 504 aged & GE; 75 years). There was no difference between the groups in terms of cumulative events defined as primary outcome (3.5% vs. 4.4%, p = 0.393). Infection related to device system was significantly higher in the & GE; 75 age group (1.8% vs. 3.4%, p = 0.034). There was no significant difference between the groups in terms of clinically significant hematoma and pneumothorax (0.7% vs. 0.4%, p = 0.451, 1.4% vs. 1.0%, p = 0.477, respectively). In multivariate model analysis, no association was found between age & GE; 75 years and infection related to the device system.ConclusionInfection rates were relatively higher in the patient group aged & GE; 75 years. This patient group should be evaluated more carefully in terms of infection development before and after the procedure.en_US
dc.identifier.doi10.1007/s40520-023-02524-6
dc.identifier.endpage2452en_US
dc.identifier.issn1594-0667
dc.identifier.issn1720-8319
dc.identifier.issue11en_US
dc.identifier.pmid37599325en_US
dc.identifier.scopus2-s2.0-85168335389en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage2445en_US
dc.identifier.urihttps://doi.org/10.1007/s40520-023-02524-6
dc.identifier.urihttps://hdl.handle.net/20.500.14034/1277
dc.identifier.volume35en_US
dc.identifier.wosWOS:001051147500001en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofAging Clinical and Experimental Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectPacemaker; Cardiovascular Implantable Electronic Devices; Complication; Elderlyen_US
dc.titleAging and cardiac implantable electronic device complications: is the procedure safe in older patients?en_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
1277.pdf
Boyut:
845.84 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu